View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
FRIDAY, Nov. 12 (HealthDay News) -- Pain at presentation may indicate a worse prognosis for patients with hepatocellular carcinoma (HCC), according to research published in the October issue of the Journal of Pain.
Brian I. Carr, M.D., and Lynette A. Pujol, Ph.D., of Thomas Jefferson University in Philadelphia, examined a large HCC database for the incidence of pain in patients with unresectable cancer to determine prognostic and clinical correlates.
The researchers found 760 patients with pain and 2,657 without pain, and determined that those with pain at presentation had a worse prognosis and more adverse tumor characteristics than those who did not have pain. Patients with pain at presentation had shorter survival, larger tumors, an increased incidence of portal vein thrombosis, and higher levels of alpha fetoprotein.
"This article presents one of the first looks at correlates of pain and survival in HCC. Results of this study could inform future research and clinical investigations regarding the importance of pain at presentation in patients with HCC, which impacts qualify of life and survival," the authors write.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top